Allergy testing and treatment for canine atopic dermatitis

Veterinary Medicine

Volumn 97, Issue 3, 2002, Pages 210-224

  Hillier, Andrew ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; ALIMEMAZINE TARTRATE; ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BENZOYL PEROXIDE; CHLORHEXIDINE; CHLORPHENIRAMINE MALEATE; CLESTAMINE FUMARATE; CYCLOSPORIN; CYPROHEPTADINE; DEXAMETHASONE; DIPHENHYDRAMINE; DOXEPIN; FLUOCINOLONE; FLUOXETINE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYZINE; IMMUNOGLOBULIN E; LACTIC ACID ETHYL ESTER; MARBOFLOXACIN; MICONAZOLE; OMEGA 6 FATTY ACID; PHENERGEN; PREDNISOLONE; PROMETHAZINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAVIST ALLERGY; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; ZENIQUIN;

ALLERGY TEST; ATOPIC DERMATITIS; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CANINE TOOTH; DIAGNOSTIC VALUE; DIARRHEA; DOG DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXCITATION; FOOD ALLERGY; GINGIVA HYPERPLASIA; IMMUNOTHERAPY; INTRACUTANEOUS TEST; LETHARGY; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; POLYDIPSIA; POLYURIA; REVIEW; SCREENING; SEROLOGY; SKIN ALLERGY; SKIN TEST; VOMITING;

EID: 0036522230     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Norman, P.S.; Lichtenstein, L.M.: The clinical and immunologic specificity of immunotherapy. J. Allergy Clin. Immunol. 61 (6):370-377; 1978.
2. Anderson, R.K.; Sousa, C.A.: Workshop report 7: In vivo vs. in vitro testing for canine atopy. Advances in Veterinary Dermatology, Vol. II (P.J. Ihrke et al., eds.). Pergamon Press, Tarrytown, N.Y., 1993; pp 425-427.
3. Codner, E.C.; Lessard, P.: Comparison of intradermal allergy test and enzyme-linked immunosorbent assay in dogs with allergic skin disease. JAVMA 202 (5):739-743; 1993.
4. Lian, T.M.; Halliwell, R.E.W.: Allergenspecific IgE and IgGd antibodies in atopic and normal dogs. Vet. Immunol. Immunopathol. 66:203-223; 1998.
5. DeBoer, D.J.; Hillier, A.: The ACVD task force on canine atopic dermatitis (XVI): Laboratory evaluation of dogs with atopic dermatitis with serum-based "allergy" tests. Vet. Immunol. Immunopathol. 81:277-287; 2001.
6. Jeffers, J.G. et al.: Diagnostic testing of dogs for food hypersensitivity. JAVMA 198 (2):245-250; 1991.
7. Mueller, R.; Tsohalis, J.: Evaluation of serum allergen-specific IgE for the diagnosis of food adverse reactions in dogs. Vet. Dermatol. 9:167-171; 1998.
8. Aeroallergens and aerobiology. Allergic Skin Diseases of the Dog and Cat, 2nd Ed. (L.M. Reedy et al., eds.). W.B. Saunders, Philadelphia, Pa., 1997; pp 50-82.
9. Barbet, J.L.; Halliwell, R.E.W.: Duration of inhibition of immediate skin test reactivity by hydroxyzine hydrochloride in dogs. JAVMA 194 (11):1565-1569; 1989.
10. Rivierre, C. et al.: Effects of a 1% hydrocortisone conditioner on the prevention of immediate and late-phase reactions in canine skin. Vet. Rec. 147 (26):739-742; 2000.
11. Kunkle, G. et al.: Steroid effects on intradermal skin testing in sensitized dogs (abst.). Proc. AAVD/ACVD, AAVD/ACVD, Charleston, S.C., 1994; 54-55.
12. Macina, M.; Helton-Rhodes, K.: An investigation on the influence of corticosteroids on antigen-specific IgE and total serum IgE in dogs using ELISA allergy testing (abst.). Proc. AAVD/ACVD, AAVD/ACVD, Santa Fe, N.M., 1995; pp 32-33.
13. Miller, W.H. et al.: The influence of oral corticosteroids or declining allergen exposure on serologic allergy test results. Vet. Dermatol. 3:237-244; 1992.
14. Hillier, A.: IgE-mediated hypersensitivity to Tyrophagus putrescentiae and Lepidoglyphus destructor storage mites in dogs in the USA (abst.). Vet. Dermatol. 12:239; 2001.
15. Vollset, I. et al.: Immediate type hypersensitivity in dogs induced by storage mites. Res. Vet. Sci. 40 (1):123-127; 1986.
16. Sture, G.H. et al.: Canine atopic disease: The prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain. Vet. Immunol. Immunopathol. 44:293-308; 1995.
17. Saridomichelakis, M.N. et al.: Canine atopic dermatitis in Greece: Clinical observations and the prevalence of positive intradermal test reactions in 91 spontaneous cases. Vet. Immunol. Immunopathol. 69 (1):61-73; 1999.
18. Noli, C.; Hillier, A.: House dust mites and allergy. Advances in Veterinary Dermatology, Vol. IV (K. Thoday et al., eds.). Butterworth Heinemann, Oxford, U.K. (in press).
19. Platts-Mills, T.A.E. et al.: The role of intervention in established allergy: Avoidance of indoor allergens in the treatment of chronic allergic disease. J. Allergy Clin. Immunol. 106 (5):787-804; 2000.
20. Griffin, C.E.; Hillier, A.: The ACVD task force on canine atopic dermatitis (XXIV): Allergen-specific immunotherapy. Vet. Immunol. Immunopathol. 81:363-383; 2001.
21. Halliwell, R.E.W.: Atopic disease in the dog. Vet. Rec. 89 (8):209-214; 1971.
22. Halliwell, R.E.W.: Hyposensitization in the treatment of atopic disease. Current Veterinary Therapy VI Small Animal Practice (R.W. Kirk, ed.). W.B. Saunders, Philadelphia, Pa., 1977; pp 537-541.
23. Nesbitt, G.H.: Canine allergic inhalant dermatitis: A review of 230 cases. JAAHA 172:55-60; 1978.
24. Reedy, L.M.: Canine atopy. Compend. Cont. Ed. 1:550-556; 1979.
25. Scott, D.W.: Observations on canine atopy. JAAHA 17:91-100; 1981.
26. Scott, K.V. et al.: A retrospective study of hyposensitization in atopic dogs in a flea-scarce environment. Advances in Veterinary Dermatology, Vol. II (P.J. Ihrke et al., eds.). Pergamon Press, Tarrytown, N.Y., 1993; pp 79-87.
27. Sousa, C.A.; Norton, A.L.: Advances in methodology for diagnosis of allergic skin disease. Vet. Clin. North Am. (Small Anim. Pract.) 20 (6):1419-1427; 1990.
28. Miller, W.H. et al.: Evaluation of the performance of a serologic allergy system in atopic dogs. JAAHA 29:545-550; 1993.
29. Mueller, R.S.; Bettenay, S.V.: Long-term immunotherapy of 146 dogs with atopic dermatitis-A retrospective study. Aust. Vet. Pract. 26:128-132; 1996.
30. Schwartzman, R.M.; Mathis, L.: Immunotherapy for canine atopic dermatitis: Efficacy in 125 atopic dogs with vaccine formulation based on ELISA allergy testing. J. Vet. Allergy Clin. Immunol. 5:144-152; 1997.
31. Nuttall, T.J. et al.: Retrospective survey of allergen immunotherapy in canine atopy. Vet. Rec. 143 (5):139-142; 1998.
32. Rosser, E.J.: Aqueous hyposensitization in the treatment of canine atopic dermatitis: A retrospective study of 100 cases. Advances in Veterinary Dermatology, Vol. III (K.W. Kwochka et al., eds.). Butterworth Heinemann, Boston, Mass., 1998; pp 169-176.
33. Park, S. et al.: Comparison of response to immunotherapy by intradermal skin test and antigen-specific IgE in canine atopy. J. Vet. Med. Sci. 62 (9):983-988; 2000.
34. Willemse, A. et al.: Effect of hyposensitization on atopic dermatitis in dogs. JAVMA 184 (10):1277-1280; 1984.
35. Griffin, C.E.: Hyposensitization. Calif. Vet. 52:18-21; 1998.
36. Power, H.T.: Why do owners discontinue immunotherapy? (abst.) Vet. Dermatol. 11 (suppl. 1):14; 2000.
37. DeBoer, D.J.; Griffin, C.E.: The ACVD task force on canine atopic dermatitis (XXI): Antihistamine pharmacotherapy. Vet. Immunol. Immunopathol. 81:323-329; 2001.
38. Paradis, M. et al.: Further investigations on the use of nonsteroidal and steroidal anti-inflammatory agents in the management of canine pruritus. JAAHA 27:44-48; 1991.
39. Paradis, M. et al.: The efficacy of clemastine (Tavist), a fatty acid-containing product (Derm Caps), and the combination of both products in the management of canine pruritus. Vet. Dermatol. 2:17-20; 1991.
40. Shoulberg, N.: The efficacy of Prozac (fluoxetine) in the treatment of acral lick granulomas and allergic inhalant dermatitis in canines (abst.). Proc. AAVD/ACVD, AAVD/ACVD, San Francisco, Calif., 1990; pp 31-32.
41. Melman, S.A.: Prozac (fluoxetine), Zoloft (sertraline) and Anafranil (clomipramine) use in animals for selected dermatological and behavioral conditions (abst). Proc. AAVD/ACVD, AAVD/ACVD, Santa Fe, N.M., 1995; p 82.
42. Olivry, T. et al: The ACVD task force on canine atopic dermatitis (XXIII): Are essential fatty acids effective? Vet. Immunol. Immunopathol. 81:347-362; 2001.
43. Logas, D.; Kunkle, G.A.: Double-blinded crossover study with marine oil supplementation containing high-dose eicosapentaenoic acid for the treatment of canine pruritic skin disease. Vet. Dermatol. 5:99-104; 1994.
44. Marsella, R.; Nicklin, C.F.: Double-blinded placebo-controlled crossover study on the effects of pentoxifylline in canine atopy. Vet. Dermatol. 11:255-260; 2000.
45. Ferrer, L. et al.: Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet. Rec. 145 (7):191-194; 1999.
46. Olivry, T. et al.: Treatment of atopic dermatitis with misoprostol, a prostaglandin E-1 analogue-An open study. J. Dermatol. Treat. 8:243-247; 1997.
47. Olivry, T. et al.: A placebo-controlled, blinded trial of misoprostol therapy for canine atopic dermatitis: Effects on dermal cellularity and cutaneous tumor necrosis factor-alpha gene transcription (abst.). Vet. Dermatol. 11:21; 2000.
48. Olivry, T. et al.: Cyclosporin-A decreases skin lesions and pruritus in dogs with atopic dermatitis: A prednisolone-controlled blinded trial (abst.). Vet. Dermatol. 11:19; 2000.
49. Gregory, C.L.: Immunosuppressive agents. Current Veterinary Therapy XIII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, Pa., 2000; pp 509-513.